Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFER | P55789 | 1/20 | 0.61 |
| ▸ | MAOB | P27338 | 4/20 | 0.58 |
| ▸ | MAOA | P21397 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | RARB | P10826 | 6/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | RARA | P10276 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | MTOR | P42345 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ANPEP | P15144 | 1/20 | 0.47 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19143887 | 0.92 | RARB (0.58) | GFERMAOBMAOAALDH1A1TP53 | |
| Terephthalic Acid SCHEMBL4612225 | 0.89 | TSHR (0.67) | ALDH1A1TP53TSHRRARBPPARA | |
| SCHEMBL70166 | 0.89 | TSHR (0.67) | ALDH1A1TP53TSHRRARBPPARA | |
| SCHEMBL6864579 | 0.87 | TSHR (0.61) | ALDH1A1TP53TSHRMAPTKMT2A | |
| Hydrochloric Acid SCHEMBL7132238 | 0.86 | TSHR (0.63) | ALDH1A1TP53TSHRRARBPPARA | |
| Terephthalic Acid SCHEMBL9717815 | 0.86 | TSHR (0.71) | ALDH1A1TP53TSHRMEN1MAPT | |
| Terephthalic Acid SCHEMBL7648718 | 0.86 | TSHR (0.71) | ALDH1A1TP53TSHRMEN1MAPT | |
| Aminobenzoic Acid SCHEMBL1768920 | 0.86 | TSHR (0.71) | ALDH1A1TP53TSHRMEN1MAPT | |
| Aminobenzoic Acid SCHEMBL8249 | 0.86 | TSHR (0.71) | ALDH1A1TP53TSHRMEN1MAPT | |
| Tyramine SCHEMBL8001426 | 0.85 | ALDH1A1 (0.62) | GFERMAOBMAOAALDH1A1RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3500627-A1 | ADDUCTS AND USES THEREOF | Huntsman Advanced Materials Americas LLC (US) | 2019-06-26 | — | — | EP | disclosed |
| WO-2018035397-A1 | ADDUCTS AND USES THEREOF | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2018-02-22 | — | — | WO | disclosed |
| EP-2772490-B1 | AMINOALKYL-SUBSTITUTED N-THIENYL BENZAMIDE DERIVATIVE | ASTELLAS PHARMA INC (JP) | 2016-04-06 | — | — | EP | disclosed |
| US-9062032-B2 | Aminoalkyl-substituted N-thienylbenzamide derivative | ASTELLAS PHARMA INC. (JP) | 2015-06-23 | — | — | US | disclosed |
| US-9062032-B2 | Aminoalkyl-substituted N-thienylbenzamide derivative | ASTELLAS PHARMA INC. (JP) | 2015-06-23 | — | — | US | disclosed |
| US-20150031727-A1 | AMINOALKYL-SUBSTITUTED N-THIENYLBENZAMIDE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2015-01-29 | — | — | US | disclosed |
| US-20150031727-A1 | AMINOALKYL-SUBSTITUTED N-THIENYLBENZAMIDE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2015-01-29 | — | — | US | disclosed |
| EP-2772490-A1 | AMINOALKYL-SUBSTITUTED N-THIENYL BENZAMIDE DERIVATIVE | Astellas Pharma Inc. (JP) | 2014-09-03 | — | — | EP | disclosed |
| EP-2726529-A1 | HYBRID EPOXY RESINS | Dow Global Technologies LLC (US) | 2014-05-07 | — | — | EP | disclosed |
| EP-2726530-A1 | HYBRID EPOXY RESIN ADDUCTS | Dow Global Technologies LLC (US) | 2014-05-07 | — | — | EP | disclosed |
| WO-2012047420-A2 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-12 | — | — | WO | disclosed |
| WO-2012044443-A1 | EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2011136843-A1 | EPOXY POLYCYCLOPENTADIENE COMPOUNDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-11-03 | — | — | WO | disclosed |
| WO-2011068645-A1 | COATING COMPOSITIONS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-06-09 | — | — | WO | disclosed |
| WO-2011068644-A1 | EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-06-09 | — | — | WO | disclosed |
| WO-2011068643-A2 | COMPOSITE COMPOSITIONS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-06-09 | — | — | WO | disclosed |
| EP-2291426-A1 | ADDUCTS OF EPOXY RESINS DERIVED FROM ALKANOLAMIDES AND A PROCESS FOR PREPARING THE SAME | Dow Global Technologies Inc. (US) | 2011-03-09 | — | — | EP | disclosed |
| EP-2283060-A1 | ADDUCTS OF EPOXY RESINS AND PROCESS FOR PREPARING THE SAME | Dow Global Technologies Inc. (US) | 2011-02-16 | — | — | EP | disclosed |
| WO-2009143038-A1 | ADDUCTS OF EPOXY RESINS DERIVED FROM ALKANOLAMIDES AND A PROCESS FOR PREPARING THE SAME | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-11-26 | — | — | WO | disclosed |
| WO-2009142898-A1 | ADDUCTS OF EPOXY RESINS AND PROCESS FOR PREPARING THE SAME | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150031727-A1 | AMINOALKYL-SUBSTITUTED N-THIENYLBENZAMIDE DERIVATIVE | SLC34A2, SLC10A2, ALPI | GFER 2766/4885MAOB 2380/4885MAOA 3967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.